comparemela.com

Page 6 - Jayasree Iyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

WHO sounds alarm over COVID-linked oxygen crisis

©UNICEF Ethiopia, Mersha / Flickr cc More than 1.1 million cylinders of oxygen are needed by COVID-19 patients in low- and middle-income countries (LMICs) every day and patients are going without because hospitals can t keep up with demand, according to the World Health Organization (WHO). To fix shortages in 20 of the countries, the WHO and its partners need $90 million in immediate funding. To fix the deficit for the next 12 months, the WHO Access to COVID Tools Accelerator (ACT-A) estimates a $1.6 billion need. It s a steep price tag, but the ACT-A s new COVID-19 Oxygen Emergency Taskforce hopes to create financial partnerships, analyze the oxygen supply chain, deliver supplies and services to the most burdened countries, and facilitate long-term changes to make medical oxygen more accessible. These dollars could help increase production and transportation of items such as medical oxygen, oxygen cylinders, and oxygen concentrators.

Can Novartis really make its medicines available to everyone?

Can Novartis really make its medicines available to everyone? Novartis launched a new strategy in sub-Saharan Africa in 2019. Sales people will no longer be incentivised by sales targets but rather by patients reached. Reuters / Baz Ratner Swiss pharma firm Novartis has said it wants everyone in the world to be able to access its products, even multi-million-dollar gene therapies. Can its experiment work? This content was published on February 10, 2021 - 09:00 February 10, 2021 - 09:00 Jessica Davis Plüss Jessica covers the good, the bad, and the ugly when it comes to big global companies and their impact in Switzerland and abroad. She’s always looking for a Swiss connection with her native San Francisco and will happily discuss why her hometown has produced some of the greatest innovations but can’t seem to solve its housing crisis.

R&D lacking on emerging infectious diseases, report finds

Infectious disease research alarmingly low

Infectious disease research ‘alarmingly low’ Inside a pharmacy in India. The COVID-19 pandemic has raised questions about equal access to medicines. Copyright: Trinity Care Foundation, (CC BY-NC-ND 2.0). This image has been cropped. Speed read Focus on COVID-19 threatens to further divert attention ‘Half of key medicines’ are missing from equitable access plans Share this article: Republish We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines: You have to credit our authors. You have to credit SciDev.Net where possible include our logo with a link back to the original article.

¿Sin ganancias no funcionan las farmacéuticas? | ACTUALIDAD | DW

¿Sin ganancias no funcionan las farmacéuticas? | ACTUALIDAD | DW
dw.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dw.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.